{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:44:43Z","timestamp":1791999883820,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,8]],"date-time":"2027-07-08T00:00:00Z","timestamp":1815004800000},"content-version":"am","delay-in-days":341,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018502","name":"Kanazawa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.dmd.2026.100348","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:20:00Z","timestamp":1782170400000},"page":"100348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CYP1A2 and ADH1C contribute to abacavir aldehyde intermediate formation in the human liver"],"prefix":"10.1016","volume":"54","author":[{"given":"Rei","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-8828","authenticated-orcid":false,"given":"Shotaro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7696-5814","authenticated-orcid":false,"given":"Nao","family":"Yoneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suemizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5988","authenticated-orcid":false,"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dmd.2026.100348_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2165\/00003495-200060020-00015","article-title":"Abacavir: a review of its clinical potential in patients with HIV infection","volume":"60","author":"Hervey","year":"2000","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.dmd.2026.100348_bib2","article-title":"Co-formulated abacavir-lamivudine-zidovudine for initial treatment of HIV infection and AIDS","volume":"2013","author":"Shey","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.dmd.2026.100348_bib3","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0149-2918(01)80132-6","article-title":"Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir","volume":"23","author":"Hetherington","year":"2001","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.dmd.2026.100348_bib4","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0149-2918(02)80057-1","article-title":"The abacavir hypersensitivity reaction: a review","volume":"24","author":"Clay","year":"2002","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.dmd.2026.100348_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.toxlet.2013.10.036","article-title":"Bioactivation to an aldehyde metabolite\u2014possible role in the onset of toxicity induced by the anti-HIV drug abacavir","volume":"224","author":"Grilo","year":"2014","journal-title":"Toxicol Lett"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100348_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0009-2797(02)00059-5","article-title":"The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes","volume":"142","author":"Walsh","year":"2002","journal-title":"Chem Biol Interact"},{"issue":"7","key":"10.1016\/j.dmd.2026.100348_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/10408440591002183","article-title":"Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health","volume":"35","author":"O\u2019Brien","year":"2005","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100348_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1208\/s12248-020-00536-y","article-title":"The role of alcohol dehydrogenase in drug metabolism: beyond ethanol oxidation","volume":"23","author":"Di","year":"2021","journal-title":"AAPS J"},{"issue":"5","key":"10.1016\/j.dmd.2026.100348_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/dmd.110.037259","article-title":"CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay","volume":"39","author":"Iwamura","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2026.100348_bib10","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1124\/dmd.118.081182","article-title":"Differences in the in vivo and in vitro metabolism of imrecoxib in humans: formation of the rate-limiting aldehyde intermediate","volume":"46","author":"Hou","year":"2018","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2026.100348_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100173","article-title":"Alcohol dehydrogenase 4 and aldo-keto reductase 1A1 catalyze the oxidation of 4-hydroxytolbutamide, a metabolite of tolbutamide, in the human liver","volume":"53","author":"Shimomura","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmd.2026.100348_bib12","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.124.001917","article-title":"Characterization of human alcohol dehydrogenase 4 and aldehyde dehydrogenase 2 as enzymes involved in the formation of 5-carboxylpirfenidone, a major metabolite of pirfenidone","volume":"53","author":"Sato","year":"2025","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"10.1016\/j.dmd.2026.100348_bib13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/dmd.109.026567","article-title":"Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis","volume":"37","author":"Watanabe","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100348_bib14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"issue":"12","key":"10.1016\/j.dmd.2026.100348_bib15","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1080\/00498254.2021.2007553","article-title":"Pirfenidone 5-hydroxylation is mainly catalysed by CYP1A2 and partly catalysed by CYP2C19 and CYP2D6 in the human liver","volume":"51","author":"Zhang","year":"2021","journal-title":"Xenobiotica"},{"issue":"6","key":"10.1016\/j.dmd.2026.100348_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003088-200847060-00001","article-title":"A review of the pharmacokinetics of abacavir","volume":"47","author":"Yuen","year":"2008","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"10.1016\/j.dmd.2026.100348_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2026.100318","article-title":"Identification of ADH isoforms catalyzing hydroxyzine oxidation using recombinant human ADH: serendipitous finding of potent ADH inhibition by organic solvents","volume":"54","author":"Tonami","year":"2026","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"10.1016\/j.dmd.2026.100348_bib18","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0006-2952(97)00359-6","article-title":"Inhibition of human mitochondrial aldehyde dehydrogenase by the disulfiram metabolite S-methyl-N,N-diethylthiocarbamoyl sulfoxide: structural characterization of the enzyme adduct by HPLC-tandem mass spectrometry","volume":"54","author":"Tomlinson","year":"1997","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100348_bib19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0091270003260336","article-title":"Human liver aldehyde oxidase: inhibition by 239 drugs","volume":"44","author":"Obach","year":"2004","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.dmd.2026.100348_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/np970237h","article-title":"Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers","volume":"61","author":"Cos","year":"1998","journal-title":"J Nat Prod"},{"issue":"3","key":"10.1016\/j.dmd.2026.100348_bib21","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1124\/dmd.30.3.235","article-title":"(+)-N-3-Benzyl-nirvanol and (-)-N-3-benzyl-phenobarbital: new potent and selective in vitro inhibitors of CYP2C19","volume":"30","author":"Suzuki","year":"2002","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmd.2026.100348_bib22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2133\/dmpk.18.287","article-title":"In vitro inhibitory effect of 1-aminobenzotriazole on drug oxidations catalyzed by human cytochrome P450 enzymes: a comparison with SKF-525A and ketoconazole","volume":"18","author":"Emoto","year":"2003","journal-title":"Drug Metab Pharmacokinet"},{"issue":"4","key":"10.1016\/j.dmd.2026.100348_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/dmd.31.4.476","article-title":"Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans","volume":"31","author":"Attar","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.dmd.2026.100348_bib24","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0090-9556(24)14947-1","article-title":"Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs","volume":"27","author":"Nakajima","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2026.100348_bib25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbrc.2023.04.054","article-title":"HepaSH cells: experimental human hepatocytes with lesser inter-individual variation and more sustainable availability than primary human hepatocytes","volume":"663","author":"Uehara","year":"2023","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/j.dmd.2026.100348_bib26","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acs.chemrestox.5b00129","article-title":"Comparison of the reactivity of trapping reagents toward electrophiles: cysteine derivatives can be bifunctional trapping reagents","volume":"28","author":"Inoue","year":"2015","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.dmd.2026.100348_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev-pharmtox-052220-105907","article-title":"Non-P450 drug-metabolizing enzymes: contribution to drug disposition, toxicity, and development","volume":"62","author":"Fukami","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"9","key":"10.1016\/j.dmd.2026.100348_bib28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1124\/dmd.117.076463","article-title":"Age-dependent protein abundance of cytosolic alcohol and aldehyde dehydrogenases in human liver","volume":"45","author":"Bhatt","year":"2017","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmd.2026.100348_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1517\/17425255.2012.663352","article-title":"The role of aldehyde oxidase in drug metabolism","volume":"8","author":"Garattini","year":"2012","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1-2","key":"10.1016\/j.dmd.2026.100348_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11010-008-9794-5","article-title":"Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1","volume":"315","author":"Miura","year":"2008","journal-title":"Mol Cell Biochem"},{"issue":"1-3","key":"10.1016\/j.dmd.2026.100348_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cbi.2008.10.058","article-title":"The human short-chain dehydrogenase\/reductase (SDR) superfamily: a bioinformatics summary","volume":"178","author":"Bray","year":"2009","journal-title":"Chem Biol Interact"},{"issue":"8","key":"10.1016\/j.dmd.2026.100348_bib32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/hep4.1530","article-title":"Nicotinamide adenine dinucleotide metabolome is functionally depressed in patients undergoing liver transplantation for alcohol-related liver disease","volume":"4","author":"Parker","year":"2020","journal-title":"Hepatol Commun"},{"issue":"6","key":"10.1016\/j.dmd.2026.100348_bib33","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S1734-1140(09)70187-2","article-title":"Effect of diethyldithiocarbamate (DDC) and ticlopidine on CYP1A2 activity and caffeine metabolism: an in vitro comparative study with human cDNA-expressed CYP1A2 and liver microsomes","volume":"61","author":"Kot","year":"2009","journal-title":"Pharmacol Rep"},{"issue":"11","key":"10.1016\/j.dmd.2026.100348_bib34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1124\/dmd.120.000089","article-title":"(\u2013)-N-3-Benzylphenobarbital is superior to omeprazole and (+)-N-3-benzylnirvanol as a CYP2C19 inhibitor in suspended human hepatocytes","volume":"48","author":"Cuypers","year":"2020","journal-title":"Drug Metab Dispos"},{"issue":"1-3","key":"10.1016\/j.dmd.2026.100348_bib35","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cbi.2010.12.005","article-title":"Oxidation of methanol, ethylene glycol, and isopropanol with human alcohol dehydrogenases and the inhibition by ethanol and 4-methylpyrazole","volume":"191","author":"Lee","year":"2011","journal-title":"Chem Biol Interact"},{"issue":"7","key":"10.1016\/j.dmd.2026.100348_bib36","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5152\/tjg.2022.21340","article-title":"Effects of gene polymorphisms, metabolic activity, and content of alcohol dehydrogenase and acetaldehyde dehydrogenases on prognosis of hepatocellular carcinoma patients","volume":"33","author":"Gao","year":"2022","journal-title":"Turk J Gastroenterol"},{"issue":"6","key":"10.1016\/j.dmd.2026.100348_bib37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.humimm.2020.02.011","article-title":"New genetic predictors for abacavir tolerance in HLA-B\u221757:01 positive individuals","volume":"81","author":"Pavlos","year":"2020","journal-title":"Hum Immunol"},{"issue":"9312","key":"10.1016\/j.dmd.2026.100348_bib38","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626006173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:52:39Z","timestamp":1791996759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626006173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0090955626006173"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100348","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP1A2 and ADH1C contribute to abacavir aldehyde intermediate formation in the human liver","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100348"}}